LadRx Corp (LADXD)

[mr10001]

Happy New Year

Oct 30, 2007 SEC Filing, S-1 Registration.
Registration statement for face-amount certificate companies

RXi PHARMACEUTICALS CORPORATION
Shares of Common Stock

This prospectus is being furnished to the holders of common stock of CytRx Corporation, or CytRx, in connection with the distribution by CytRx to its stockholders of 4,526,624 outstanding shares of common stock of RXi Pharmaceuticals Corporation, or RXi, held by CytRx. The RXi shares being distributed under this prospectus will constitute approximately 36% of RXi's outstanding shares immediately following the distribution. Concurrently with the distribution, CytRx is awarding approximately 83,714 additional outstanding shares of RXi common stock held by CytRx to some of its directors, officers and employees. The award of RXi shares by CytRx is being made pursuant to a separate award prospectus dated the date of this prospectus. Immediately following the distributions made under this prospectus and the award made under the award prospectus, CytRx will own approximately 49% of the outstanding shares of RXi common stock, which shares are concurrently being registered for future resale by CytRx at such times and prices as it may choose pursuant to a separate resale prospectus also dated the date of this prospectus.

FYI